Skip to content
CancerIndex

Publication

Patient-reported outcomes as non-muscle-invasive bladder cancer clinical trial endpoints.

Kimberly Toumazos, Spencer Bell, Katelyn Spencer, Darrell Nakagawa, Kelly K Bree, Ashish M Kamat, Sarah P Psutka, Patrick J Hensley

BJU internationalSep 28, 2026PMID 42806610doi:10.1111/bju.70461 Journal ArticlepubmedProvenance
Source
PubMed
Retrieved
Sep 30, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20260930-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

OBJECTIVE: To evaluate the frequency at which patient-reported outcomes (PROs) are incorporated as nonmuscle-invasive bladder cancer (NMIBC) clinical trial endpoints. PATIENTS AND METHODS: Interventional trials limited to patients with NMIBC were queried from clinicaltrials.gov from 1994 to 2025…

Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Candidate 1

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.